APA (7th ed.) Citation

Z, X., F, G., L, L., Y, G., H, J., W, Z., & J, W. (2025). Acetylcarnitine in cerebrospinal fluid and blood as a protective factor for neuromyelitis optica spectrum disorders: A mendelian randomization study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 46(12), 6697. https://doi.org/10.1007/s10072-025-08432-z

Chicago Style (17th ed.) Citation

Z, Xie, Gai F, Liu L, Guo Y, Jiang H, Zhang W, and Wang J. "Acetylcarnitine in Cerebrospinal Fluid and Blood as a Protective Factor for Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 46, no. 12 (2025): 6697. https://doi.org/10.1007/s10072-025-08432-z.

MLA (9th ed.) Citation

Z, Xie, et al. "Acetylcarnitine in Cerebrospinal Fluid and Blood as a Protective Factor for Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 46, no. 12, 2025, p. 6697, https://doi.org/10.1007/s10072-025-08432-z.